Avadel Pharmaceuticals Plc - Company Profile

Powered by

All the sales intelligence you need on Avadel Pharmaceuticals Plc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Avadel Pharmaceuticals Plc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Avadel Pharmaceuticals Plc.

Back to companies

Avadel Pharmaceuticals Plc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

The following section provides information on Avadel Pharmaceuticals Plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Avadel Pharmaceuticals Plc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Geoffrey M. Glass

Chairman Executive Board Since: 2018 Age: 51

Mr. Geoffrey M. Glass has been the Chairman of the company since 2018. Prior to this, he served as a Director of the company. Previously, he served as the Chief Executive Officer of Sancilio Pharmaceuticals. Mr. Glass also served as a Director of Locus Biosciences. Before that, he served as a Member of Executive Committee of Patheon N.V. Mr. Glass also serves as the Chief Executive Officer of Kiniciti LLC and the Chairman of Ncardina and Abzena.

Read Hide full bio of Geoffrey M. Glass

Gregory J. Divis

Director; Chief Executive Officer Executive Board Since: 2019 Age: 58

Mr. Gregory J. Divis has been the Chief Executive Officer and Director of the company since 2019. Prior to this, he served as the Interim Chief Executive Officer, Chief Commercial Officer, and Executive Vice President of the company. Previously, he served at Linden Capital Partners as an Executive in Residence. Mr. Divis also served as the Chief Executive Officer and President at Lumara Health. He served in various roles including Sales, Marketing, General Management, and Business Development at Sanofi-Aventis and Schering Plough.

Read Hide full bio of Gregory J. Divis

Thomas S. McHugh

Chief Financial Officer Senior Management Since: 2019 Age: 60

Mr. Thomas McHugh has been the Chief Financial Officer of the company since 2019. Prior to this, he served as the Senior Vice President at Ironshore Pharmaceutical Inc. Mr. McHugh also served as the Treasurer and Chief Financial Officer of K.V Pharmaceutical Co.

Read Hide full bio of Thomas S. McHugh

Susan Rodriguez

Chief Operating Officer Senior Management Since: 2025

Ms. Susan Rodriguez has been the Chief Operating Officer of the company since 2025. Prior to this, she served as the Chief Commercial Officer of Ardelyx. Previously, she served as the Chief Executive Officer of Tolmar Pharmaceuticals. Ms. Rodriguez also served as the Divisional Vice President of Global Marketing at Abbott Laboratories.

Read Hide full bio of Susan Rodriguez

Polly Murphy

Chief Business Officer Senior Management Since: 2024

Ms. Polly Murphy has been the Chief Business Officer of the company since 2024. Prior to this, she served as the Chief Business Officer of UroGen Pharma. Previously, she served as the Vice President, Commercial Development at Pfizer.

Read Hide full bio of Polly Murphy
Gain a 360-degree view of Avadel Pharmaceuticals Plc and make more informed decisions for your business Gain a 360-degree view of Avadel Pharmaceuticals Plc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer